Article Versions Notes

Meier L, de Melo MFCV, Abreu HR, Oliveira IMe, Sens L, Doring TH, Krogh R, Beatriz A, Andricopulo AD, Saba S, et al. In Silico Studies and Biological Evaluation of Thiosemicarbazones as Cruzain-Targeting Trypanocidal Agents for Chagas Disease. Pharmaceutics. 2026; 18(1):65. https://doi.org/10.3390/pharmaceutics18010065

Meier, Lidiane, Milena F. C. V. de Melo, Heitor R. Abreu, Isabella M. e Oliveira, Larissa Sens, Thiago H. Doring, Renata Krogh, Adilson Beatriz, Adriano D. Andricopulo, Sumbal Saba, and et al. 2026. "In Silico Studies and Biological Evaluation of Thiosemicarbazones as Cruzain-Targeting Trypanocidal Agents for Chagas Disease" Pharmaceutics 18, no. 1: 65. https://doi.org/10.3390/pharmaceutics18010065

Meier, L., de Melo, M. F. C. V., Abreu, H. R., Oliveira, I. M. e., Sens, L., Doring, T. H., Krogh, R., Beatriz, A., Andricopulo, A. D., Saba, S., de Oliveira, A. S., & Rafique, J. (2026). In Silico Studies and Biological Evaluation of Thiosemicarbazones as Cruzain-Targeting Trypanocidal Agents for Chagas Disease. Pharmaceutics, 18(1), 65. https://doi.org/10.3390/pharmaceutics18010065